搜索结果 | 泌尿系统常见疾病循证医学证据

搜索结果

共搜索到4条与Int Braz J Urol有关的结果

Prevalence and risk factors of incidental prostate cancer in certain surgeries for benign prostatic hyperplasia: A systematic review and meta-analysis

2022年发布于 Int Braz J Urol 47卷第期

Guo Z. He J. Huang L. Wang Z. Hu P. Wang S. Bai Z. Pan J.

Meta-Analysis as Topic Prevalence Risk Factors Prostatic Hyperplasia
文献简介 原文链接
Diagnostic Accuracy of Novel Urinary Biomarker Tests in Non-muscle-invasive Bladder Cancer: A Systematic Review and Network Meta-analysis (vol 4, pg 927, 2021)

 2022 年发布于 Int Braz J Urol 40 卷第 1 期

Laukhtina E. Shim S. R. Mori K. D'Andrea D. Soria F. Rajwa P. Mostafaei H. Comperat E. Cimadamore A. Moschini M. Teoh J. Y. C. Enikeev D. Xylinas E. Lotan Y. Palou J. Gontero P. Babjuk M. Witjes J. A. Kamat A. M. Roupret M. Shariat S. F. Pradere B.

Bcg Bacillus Calmette–Guérin Nmibc bladder cancer checkpoint inhibition therapy nadofaragene firadenovec non muscle invasive oncolytic viruses
文献简介 原文链接
Diagnostic performance of nuclear matrix protein 22 and urine cytology for bladder cancer: A meta-analysis

 2022 年发布于 Int Braz J Urol 82 卷第 7 期

Wang J. Zhao X. Jiang X. L. Lu D. Yuan Q. Li J.

Adjuvants Immunologic Administration Intravesical BCG Vaccine/therapeutic use Bayes Theorem *Covid-19 Duration of Therapy Humans *Mycobacterium bovis Neoplasm Invasiveness Neoplasm Recurrence Local/drug therapy Network Meta-Analysis Pandemics *Urinary Bladder Neoplasms/drug therapy *Urology
文献简介 原文链接
Systematic Review and Cumulative Analysis of the Combination of Mitomycin C plus Bacillus Calmette-Guerin (BCG) for Non-Muscle-Invasive Bladder Cancer

 2017 年发布于 Int Braz J Urol 95 卷第期

Deng T. Liu B. Duan X. L. Zhang T. Cai C. Zeng G. H.

文献简介 原文链接

Prevalence and risk factors of incidental prostate cancer in certain surgeries for benign prostatic hyperplasia: A systematic review and meta-analysis

2022年 发布于 Int Braz J Urol 47卷 第期

Guo Z. He J. Huang L. Wang Z. Hu P. Wang S. Bai Z. Pan J.

Diagnostic Accuracy of Novel Urinary Biomarker Tests in Non-muscle-invasive Bladder Cancer: A Systematic Review and Network Meta-analysis (vol 4, pg 927, 2021)

 2022 年 发布于 Int Braz J Urol 40 卷 第 1 期

Laukhtina E. Shim S. R. Mori K. D'Andrea D. Soria F. Rajwa P. Mostafaei H. Comperat E. Cimadamore A. Moschini M. Teoh J. Y. C. Enikeev D. Xylinas E. Lotan Y. Palou J. Gontero P. Babjuk M. Witjes J. A. Kamat A. M. Roupret M. Shariat S. F. Pradere B.

Diagnostic performance of nuclear matrix protein 22 and urine cytology for bladder cancer: A meta-analysis

 2022 年 发布于 Int Braz J Urol 82 卷 第 7 期

Wang J. Zhao X. Jiang X. L. Lu D. Yuan Q. Li J.

Systematic Review and Cumulative Analysis of the Combination of Mitomycin C plus Bacillus Calmette-Guerin (BCG) for Non-Muscle-Invasive Bladder Cancer

 2017 年 发布于 Int Braz J Urol 95 卷 第期

Deng T. Liu B. Duan X. L. Zhang T. Cai C. Zeng G. H.

2022年发布于 Int Braz J Urol 47卷第期

 2022 年发布于 Int Braz J Urol 40 卷第 1 期

 2022 年发布于 Int Braz J Urol 82 卷第 7 期

 2017 年发布于 Int Braz J Urol 95 卷第期